BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7301534)

  • 21. [Radiation-induced cancer following radiotherapy for malignancies (author's transl)].
    Sakai K; Hinata H; Kitamura T; Shiina M; Inakoshi H; Saito M; Sueyama H
    Rinsho Hoshasen; 1981 Aug; 26(8):865-9. PubMed ID: 7289148
    [No Abstract]   [Full Text] [Related]  

  • 22. [Second cancers following radiotherapy of malignant tumors. The second mail survey in Japan].
    Sakai K; Kitamura T; Hinata H; Yamashita H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Jun; 46(6):811-8. PubMed ID: 3786119
    [No Abstract]   [Full Text] [Related]  

  • 23. [Retrospective survey on medical irradiation and leukemogenesis in Japan].
    Kitabatake T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1966 Oct; 26(7):882-90. PubMed ID: 5231998
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the risk due to medical irradiation].
    Hashizume T
    Rinsho Hoshasen; 1981 Feb; 26(2):335-8. PubMed ID: 7289130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Estimation of the mean cost of collective dose per capita in various countries of the world].
    Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1059-61. PubMed ID: 4080525
    [No Abstract]   [Full Text] [Related]  

  • 26. [Estimation of population doses from radiation beam-therapy. I. The number of irradiations, fields and patients (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Tateno Y
    Newsl Int Coll Dent India Sect; 1980 Jan; 40(1):52-61. PubMed ID: 6768054
    [No Abstract]   [Full Text] [Related]  

  • 27. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 3. Per caput mean marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):216-24. PubMed ID: 1066648
    [No Abstract]   [Full Text] [Related]  

  • 28. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
    [No Abstract]   [Full Text] [Related]  

  • 29. [Estimations of stochastic risk from medical X-ray diagnosis (author's transl)].
    Hashizume T; Maruyama T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Feb; 39(2):170-3. PubMed ID: 450654
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of sarcoidosis-cases by mass-x-ray examination in Geneva 1966-1975 (author's transl)].
    Press P
    Z Erkr Atmungsorgane; 1977 Jul; 149(1):24-32. PubMed ID: 607624
    [No Abstract]   [Full Text] [Related]  

  • 31. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 1. The number of radiographs, radiographic and fluoroscopic examinations (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(1):47-55. PubMed ID: 1063369
    [No Abstract]   [Full Text] [Related]  

  • 32. [Population doses from beam therapy in Japan 1978. Part 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Shiragai A; Noda Y; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):466-75. PubMed ID: 7422474
    [No Abstract]   [Full Text] [Related]  

  • 33. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. I. The number of medical examinations using radiopharmaceuticals (author's transl)].
    Hashizume T; Maruyama T; Tateno Y; Yamaguchi H; Nishizawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Mar; 39(3):267-76. PubMed ID: 440920
    [No Abstract]   [Full Text] [Related]  

  • 34. [Estimation of population doses from brachytherapy in Japan (author's transl)].
    Hashizume T; Maruyama T; Nishizawa K; Fukuhisa K; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1975; 35(11):1022-31. PubMed ID: 1063360
    [No Abstract]   [Full Text] [Related]  

  • 35. [Maxillofacial radiation-induced cancers (author's transl)].
    Bataini JP; Chavanne G; Brugere J; Mazabraud A
    Rev Stomatol Chir Maxillofac; 1979; 80(3):178-82. PubMed ID: 288162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of risk due to medical irradiation].
    Hashizume T
    Rinsho Hoshasen; 1981 Jan; 26(1):167-70. PubMed ID: 7218536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Second malignancies following radiotherapy: an analysis of 54 cases accumulated by mail survey in Japan].
    Matsumoto Y; Nishimura T; Hirota S; Kanesaka N; Ogo E; Nakamura R; Monzen Y; Sakai K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Jan; 62(1):27-31. PubMed ID: 11857951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stochastic risk estimation from medical x-ray diagnostic examinations. 2. Risk estimates of individuals from x-ray diagnosis (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Iwai K; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):59-70. PubMed ID: 7232112
    [No Abstract]   [Full Text] [Related]  

  • 39. Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation.
    de Vathaire F; Shamsaldin A; Grimaud E; Campbell S; Guerra M; Raquin M; Bessa E; Hardiman C; Jan P; Rumeau N
    C R Acad Sci III; 1995 Apr; 318(4):483-90. PubMed ID: 7648361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Population doses from brachytherapy in Japan, 1979 (author's transl)].
    Hashizume T; Maruyama T; Nishizawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):878-84. PubMed ID: 7454535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.